Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction

Acute coronary syndrome (ACS) is a term used to describe major cardiovascular diseases, and treatment of in-stent restenosis in patients with ACS remains a major clinical challenge. Further investigation into molecular markers of ACS may aid early diagnosis, and the treatment of ACS and post-treatme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ming Shen, Rui Gong, Haibin Li, Zhihui Yang, Yunpeng Wang, Dandan Li
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/e88ec20cb5a942f7a3a83514f95337a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e88ec20cb5a942f7a3a83514f95337a1
record_format dspace
spelling oai:doaj.org-article:e88ec20cb5a942f7a3a83514f95337a12021-11-11T14:23:43ZIdentification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction2165-59792165-598710.1080/21655979.2021.2003932https://doaj.org/article/e88ec20cb5a942f7a3a83514f95337a12021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003932https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Acute coronary syndrome (ACS) is a term used to describe major cardiovascular diseases, and treatment of in-stent restenosis in patients with ACS remains a major clinical challenge. Further investigation into molecular markers of ACS may aid early diagnosis, and the treatment of ACS and post-treatment recurrence. In the present study, total RNA was extracted from the peripheral blood samples of 3 patients with ACS, 3 patients with percutaneous coronary intervention (PCI)_non-restenosis, 3 patients with PCI_restenosis and 3 healthy controls. Subsequently, RNA library construction and high-throughput sequencing were performed. DESeq2 package in R was used to screen genes that were differentially expressed between the different samples. Moreover, the intersection of the differentially expressed mRNAs (DEmRNAs) and differentially expressed long noncoding RNAs (DElncRNAs) obtained. GeneCodis4.0 was used to perform function enrichment for DEmRNAs, and lncRNA-mRNA co-expression network was constructed. The GSE60993 dataset was utilized for diagnostic analysis, and the aforementioned investigations were verified using in vitro studies. Results of the present study revealed a large number of DEmRNAs and DElncRNAs in the different groups. We selected genes in the top 10 of differential expression and also involved in the co-expression of lncRNA-mRNA for diagnostic analysis in the GSE60993 dataset. The area under curve (AUC) of PDZK1IP1 (0.747), PROK2 (0.769) and LAMP3 (0.725) were all >0.7. These results indicated that the identified mRNAs and lncRNAs may act as potential clinical biomarkers, and more specifically, PDZK1IP1, PROK2 and LAMP3 may act as potential biomarkers for the diagnosis of ACS.Ming ShenRui GongHaibin LiZhihui YangYunpeng WangDandan LiTaylor & Francis Grouparticleacute coronary syndromemrnalong non-coding rnadifferential expressiondiagnosticBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic acute coronary syndrome
mrna
long non-coding rna
differential expression
diagnostic
Biotechnology
TP248.13-248.65
spellingShingle acute coronary syndrome
mrna
long non-coding rna
differential expression
diagnostic
Biotechnology
TP248.13-248.65
Ming Shen
Rui Gong
Haibin Li
Zhihui Yang
Yunpeng Wang
Dandan Li
Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
description Acute coronary syndrome (ACS) is a term used to describe major cardiovascular diseases, and treatment of in-stent restenosis in patients with ACS remains a major clinical challenge. Further investigation into molecular markers of ACS may aid early diagnosis, and the treatment of ACS and post-treatment recurrence. In the present study, total RNA was extracted from the peripheral blood samples of 3 patients with ACS, 3 patients with percutaneous coronary intervention (PCI)_non-restenosis, 3 patients with PCI_restenosis and 3 healthy controls. Subsequently, RNA library construction and high-throughput sequencing were performed. DESeq2 package in R was used to screen genes that were differentially expressed between the different samples. Moreover, the intersection of the differentially expressed mRNAs (DEmRNAs) and differentially expressed long noncoding RNAs (DElncRNAs) obtained. GeneCodis4.0 was used to perform function enrichment for DEmRNAs, and lncRNA-mRNA co-expression network was constructed. The GSE60993 dataset was utilized for diagnostic analysis, and the aforementioned investigations were verified using in vitro studies. Results of the present study revealed a large number of DEmRNAs and DElncRNAs in the different groups. We selected genes in the top 10 of differential expression and also involved in the co-expression of lncRNA-mRNA for diagnostic analysis in the GSE60993 dataset. The area under curve (AUC) of PDZK1IP1 (0.747), PROK2 (0.769) and LAMP3 (0.725) were all >0.7. These results indicated that the identified mRNAs and lncRNAs may act as potential clinical biomarkers, and more specifically, PDZK1IP1, PROK2 and LAMP3 may act as potential biomarkers for the diagnosis of ACS.
format article
author Ming Shen
Rui Gong
Haibin Li
Zhihui Yang
Yunpeng Wang
Dandan Li
author_facet Ming Shen
Rui Gong
Haibin Li
Zhihui Yang
Yunpeng Wang
Dandan Li
author_sort Ming Shen
title Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
title_short Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
title_full Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
title_fullStr Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
title_full_unstemmed Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction
title_sort identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mrna-lncrna co-expression network construction
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/e88ec20cb5a942f7a3a83514f95337a1
work_keys_str_mv AT mingshen identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
AT ruigong identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
AT haibinli identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
AT zhihuiyang identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
AT yunpengwang identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
AT dandanli identificationofkeymolecularmarkersofacutecoronarysyndromeusingperipheralbloodtranscriptomesequencinganalysisandmrnalncrnacoexpressionnetworkconstruction
_version_ 1718438999243096064